NEW YORK – Diagenode and MGI, a unit of BGI Group, said on Thursday that they have signed an agreement to comarket Diagenode's next-gen sequencing library preparation products in the US, Europe, and Asia Pacific.
Under the terms of the non-exclusive deal, the companies have made Diagenode's D-Plex library preparation products available on MGI's sequencing platforms. They will jointly market and promote Diagenode's solutions for epigenetic discoveries, including the D-Plex small RNA sequencing technology, formatted to work with MGI's DNBSeq sequencers.
"This important collaboration leverages the strengths of both companies and provides an opportunity to extend our capabilities and advanced sequencing technology for our customers working in cancer, neurology, autoimmune disease, and other genomic applications,” said Duncan Yu, president of MGI, in a statement.